HomeCompareBTMSX vs JNJ

BTMSX vs JNJ: Dividend Comparison 2026

BTMSX yields 3.05% · JNJ yields 3.36%● Live data

vsPost on X →
After 10 years · $10,000 invested · DRIP enabled
🏆 BTMSX wins by $4.3K in total portfolio value
10 years
BTMSX
BTMSX
● Live price
3.05%
Share price
$10.03
Annual div
$0.31
5Y div CAGR
0%
Payout ratio
50%
After 10 yrs · $10,000 · DRIP
Portfolio value
$24.3K
Annual income
$371.59
Full BTMSX calculator →
JNJ
Johnson & Johnson
● Live price
3.36%
Share price
$147.50
Annual div
$4.96
5Y div CAGR
5.8%
Payout ratio
55%
After 10 yrs · $10,000 · DRIP
Portfolio value
$20.0K
Annual income
$827.78
Full JNJ calculator →

Portfolio growth — BTMSX vs JNJ

📍 BTMSX pulled ahead of the other in Year 1

Annual dividend income

🛡️

Recession Test — Did They Cut Dividends?

How each stock treated shareholders during the 3 biggest crises of the last 20 years

Crisis PeriodBTMSXJNJ
2008–2009
GFC
— No data— No data
2020 Q1–Q2
COVID
— No data— No data
2022 Q4
Rate Hike
— No data— No data
Based on dividend payment history. "Increased" = dividend grew during crisis. "Maintained" = held within 3%. "Cut" = reduced by more than 3%.
📅

Dividend Calendar Overlap

Combined, BTMSX + JNJ cover 0 of 12 monthsgood coverage

Jan
Feb
Mar
Apr
May
Jun
Jul
Aug
Sep
Oct
Nov
Dec
BTMSX pays
JNJ pays
Both pay
Neither
💰

Tax Bracket Optimizer

Which stock is actually better after tax? Adjust your rate to find out.

BTMSX
Annual income on $10K today (after 15% tax)
$259.47/yr
After 10yr DRIP, annual income (after tax)
$315.85/yr
JNJ
Annual income on $10K today (after 15% tax)
$285.83/yr
After 10yr DRIP, annual income (after tax)
$703.61/yr
At 15% tax rate, JNJ beats the other by $387.76/year in after-tax income after 10 years on $10,000
⚖️

Lazy Portfolio Split Optimizer

What's the optimal mix of BTMSX + JNJ for your $10,000?

BTMSX: 50%JNJ: 50%
100% JNJ50/50100% BTMSX
Portfolio after 10yr
$22.2K
Annual income
$599.69/yr
Blended yield
2.70%
📊

Analyst Conviction Gap

Where Wall Street is most bullish on JNJ right now

BTMSX
No analyst data
Price Target
$26.00
+159.2% upside vs current
Range: $26.00 — $26.00
JNJ
Analyst Ratings
20
Buy
17
Hold
3
Sell
Consensus: Buy
Price Target
$228.73
+55.1% upside vs current
Range: $190.00 — $265.00
Altman Z
5.2
Piotroski
4/9
Analyst ratings via FMP. Altman Z-Score: >3.0 safe, 1.81–3.0 grey zone, <1.81 distress. Piotroski: 7–9 strong, 0–3 weak.
🏛️

Copy Congress — What Are Politicians Buying?

Senate & House STOCK Act disclosures (last 90 days)

BTMSX buys
0
JNJ buys
0
No recent congressional trades found for BTMSX or JNJ in the last 90 days.
STOCK Act mandates disclosure within 45 days of transaction. Data via FMP.Full tracker →
MetricBTMSXJNJ
Forward yield3.05%3.36%
Annual dividend / share$0.31$4.96
Payout ratio50%55%
1-year div growth0%4.2%
5-year div CAGR0%5.8%
Portfolio after 10y$24.3K$20.0K
Annual income after 10y$371.59$827.78
Total dividends collected$3.4K$5.6K
Payment frequencyquarterlyquarterly
SectorStockHealthcare
Analyst price target$26.00$228.73

Year-by-year: BTMSX vs JNJ ($10,000, DRIP)

YearBTMSX PortfolioBTMSX Income/yrJNJ PortfolioJNJ Income/yrGap
1← crossover$11,005$305.25$10,676$355.77+$329.00BTMSX
2$12,090$313.96$11,407$389.39+$683.00BTMSX
3$13,258$322.33$12,198$426.53+$1.1KBTMSX
4$14,517$330.37$13,056$467.62+$1.5KBTMSX
5$15,871$338.06$13,987$513.12+$1.9KBTMSX
6$17,327$345.42$14,998$563.56+$2.3KBTMSX
7$18,893$352.44$16,098$619.52+$2.8KBTMSX
8$20,574$359.14$17,295$681.69+$3.3KBTMSX
9$22,380$365.52$18,599$750.82+$3.8KBTMSX
10$24,318$371.59$20,022$827.78+$4.3KBTMSX

BTMSX vs JNJ: Complete Analysis 2026

BTMSXStock

The fund normally invests at least 80% of its net assets in municipal bonds and debentures, the income from which is exempt from federal income tax (including the federal alternative minimum tax ("AMT")). It invests in a broadly diversified portfolio of federally tax-exempt municipal obligations issued by governmental authorities throughout the U.S. and its territories. The fund may invest in all types of municipal obligations, including pre-refunded bonds, general obligation bonds, revenue bonds, and municipal lease participations.

Full BTMSX Calculator →

JNJHealthcare

Johnson & Johnson is a Dividend King with 62+ years of consecutive dividend increases. A healthcare conglomerate spanning pharmaceuticals, MedTech, and consumer health. JNJ spun off its consumer segment as Kenvue in 2023, focusing on higher-margin pharma and medical devices.

Full JNJ Calculator →
📬

Get this BTMSX vs JNJ comparison by email

Save your analysis + weekly dividend insights. Free forever.

More comparisons

BTMSX vs SCHDBTMSX vs JEPIBTMSX vs OBTMSX vs KOBTMSX vs MAINBTMSX vs ABBVBTMSX vs MRKBTMSX vs PFE

⚠️ Educational purposes only. Not financial advice. Congressional trades sourced from SEC STOCK Act filings via FMP. Past performance does not guarantee future results.